State Street’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$725K Buy
+35,896
New +$946K ﹤0.01% 3594

Other funds holding BRVE

State Street's BRVE Position: Q3 2026 in Review

State Street opened a new position in Braveheart Bio (BRVE) in Q3 2026: 35,896 shares worth $725K. The stake represents ﹤0.01% of the portfolio and ranks #3594 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • State Street held 35,896 shares of Braveheart Bio worth $725K as of Q3 2026.
  • Braveheart Bio was a new State Street position in Q3 2026.
  • Braveheart Bio made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3594 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.